Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis

被引:0
|
作者
Kohei Fujita
Hirotsugu Ohkubo
Akiko Nakano
Norihisa Takeda
Kensuke Fukumitsu
Satoshi Fukuda
Yoshihiro Kanemitsu
Takehiro Uemura
Tomoko Tajiri
Ken Maeno
Yutaka Ito
Tetsuya Oguri
Yoshiyuki Ozawa
Takayuki Murase
Akio Niimi
机构
[1] Nagoya City University Graduate School of Medical Sciences,Department of Respiratory Medicine, Allergy and Clinical Immunology
[2] Nagoya City University East Medical Center,Department of Respiratory Medicine
[3] Nagoya City University Graduate School of Medical Sciences,Department of Radiology
[4] Nagoya City University,Department of Pathology and Molecular Diagnostics, Graduate School of Medical Sciences
来源
关键词
Idiopathic pulmonary fibrosis; Sarcopenia; Cystatin C; Creatinine; Bioelectrical impedance; Patient-reported outcomes;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis
    Fujita, Kohei
    Ohkubo, Hirotsugu
    Nakano, Akiko
    Takeda, Norihisa
    Fukumitsu, Kensuke
    Fukuda, Satoshi
    Kanemitsu, Yoshihiro
    Uemura, Takehiro
    Tajiri, Tomoko
    Maeno, Ken
    Ito, Yutaka
    Oguri, Tetsuya
    Ozawa, Yoshiyuki
    Murase, Takayuki
    Niimi, Akio
    [J]. BMC PULMONARY MEDICINE, 2022, 22 (01)
  • [2] Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with chronic obstructive pulmonary disease
    Hirai, Kuniaki
    Tanaka, Akihiko
    Homma, Tetsuya
    Goto, Yuiko
    Akimoto, Kaho
    Uno, Tomoki
    Yoshitaka, Uchida
    Miyata, Yoshito
    Inoue, Hideki
    Ohta, Shin
    Suzuki, Shintaro
    Sagara, Hironori
    [J]. CLINICAL NUTRITION, 2021, 40 (03) : 1274 - 1280
  • [3] Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with gastric cancer
    Sun, Jing
    Yang, Hui
    Cai, Wentao
    Zheng, Jingwei
    Shen, Ningzhe
    Yang, Xinxin
    Pan, Bujian
    Zhang, Weiteng
    Chen, Xiaodong
    Shen, Xian
    [J]. BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [4] Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with gastric cancer
    Jing Sun
    Hui Yang
    Wentao Cai
    Jingwei Zheng
    Ningzhe Shen
    Xinxin Yang
    Bujian Pan
    Weiteng Zhang
    Xiaodong Chen
    Xian Shen
    [J]. BMC Gastroenterology, 22
  • [5] Decreased the creatinine to cystatin C ratio is a surrogate marker of sarcopenia in patients with type 2 diabetes
    Osaka, Takafumi
    Hamaguchi, Masahide
    Hashimoto, Yoshitaka
    Ushigome, Emi
    Tanaka, Muhei
    Yamazaki, Masahiro
    Fukui, Michiaki
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 139 : 52 - 58
  • [6] Serum creatinine/cystatin C ratio is a systemic marker of sarcopenia in patients with gastrointestinal stromal tumours
    Ding, Ping'an
    Guo, Honghai
    Sun, Chenyu
    Chen, Shuya
    Yang, Peigang
    Tian, Yuan
    Lowe, Scott
    Zhao, Qun
    [J]. FRONTIERS IN NUTRITION, 2022, 9
  • [7] Serum creatinine-to-cystatin C ratio as an indicator of sarcopenia in hemodialysis patients
    Yajima, Takahiro
    Yajima, Kumiko
    [J]. CLINICAL NUTRITION ESPEN, 2023, 56 : 200 - 206
  • [8] THE SERUM CREATININE TO CYSTATIN C RATIO; A POSSIBLE NEW SURROGATE MARKER FOR BONE MINERAL DENSITY
    Yoshii, Ichiro
    Chijiwa, Tatsumi
    Sawada, Naoya
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1897 - 1897
  • [9] The Ratio Serum Creatinine/Serum Cystatin C (a Surrogate Marker of Muscle Mass) as a Predictor of Hospitalization in Chronic Obstructive Pulmonary Disease Outpatients
    Antonio Amado, Carlos
    Teresa Garcia-Unzueta, Maria
    Alio Lavin, Bernardo
    Raul Guerra, Armando
    Aguero, Juan
    Ramos, Laura
    Munoz, Pedro
    [J]. RESPIRATION, 2019, 97 (04) : 302 - 309
  • [10] CLINICAL SIGNIFICANCE OF SERUM CREATININE-TO-CYSTATIN C RATIO AS A SURROGATE MARKER FOR INCIDENT OSTEOPOROTIC FRACTURE
    Yoshii, I.
    Sawada, N.
    Chijiwa, T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1627 - 1627